FindMyRecallSubscribe
Class I: serious health riskOngoing

Boulla VitalityXtra Capsules Recall

VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by…

Boulla LLC · Sacramento, CA

Risk level
Class I
Reported by FDA
Dec 11, 2024
Recall ID
D-0083-2025
Check your lot numberHow we source this data

Summary

Boulla recalled VitalityXtra Capsules starting Nov 4, 2024. The FDA classified it as Class I (serious health risk) and published enforcement report D-0083-2025 on Dec 11, 2024. Reason: Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac. Status: Ongoing.

Why it was recalled

Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.

Product description

VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.com

Lot numbers, UPCs & expiration codes

Lot #: 230811, Exp: 08/11/2025

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0083-2025
Classification
Class I
Status
Ongoing
Recall initiated
Nov 4, 2024
FDA report date
Dec 11, 2024
Quantity
Unknown
Recall type
Voluntary: Firm initiated
Recalling firm
Boulla LLC

Original FDA data

Every field from FDA enforcement report D-0083-2025, exactly as published.

Show all FDA fields
City
Sacramento
State
CA
Status
Ongoing
Country
United States
Event ID
95714
Address
2108 N ST #7929
Code information
Lot #: 230811, Exp: 08/11/2025
Postal code
95816
Report date
Dec 11, 2024
Product type
Drugs
Recall number
D-0083-2025
Classification
Class I
Recalling firm
Boulla LLC
Product quantity
Unknown
Reason for recall
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Voluntary / mandated
Voluntary: Firm initiated
Product description
VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.com
Distribution pattern
Nationwide within the United States
Recall initiation date
Nov 4, 2024
Initial firm notification
E-Mail
Center classification date
Dec 2, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0083-2025, published Dec 11, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls